Yoga for Health-Related Quality of Life in Adult Cancer: A Randomized Controlled Feasibility Study
Table 5
Summary of QOL-CA/CS results.
Participants
QOL-CA/CS
QOL-CA/CS
Change in Results
Mean Difference
Approaching Clinical Significanc
Incomplete Data
Baseline
Post-Intervention
Improve
Decline
A1
6.1
7.0
•
1.0
•
A2
5.8
—
—
•
A3
4.2
4.4
•
0.2
A4
3.5
2.8
•
−0.8
•
A5
5.8
8.0
•
2.2
•
Group A Average (SD)
4.9 (1.2)
5.5 (2.4)
0.7 (1.3)
95% CI
2.9 to 6.8
1.7 to 9.4
−1.4 to 2.7
B1
7.9
7.3
•
−0.7
B2
5.9
7.0
•
1.1
•
B3
5.1
4.7
•
−0.4
B4
4.2
—
—
•
B5
5.6
5.3
•
−0.3
Group B Average (SD)
6.1 (1.2)
6.1 (1.2)
−0.1 (0.8)
95% CI
4.2 to 8.1
4.1 to 8.0
−1.4 to 1.1
C1
6.8
6.6
•
−0.2
C2
3.8
4.6
•
0.9
•
C3
6.9
7.1
•
0.3
C4
4.0
3.8
•
−0.2
C5
4.1
—
•
Group C Average (SD)
5.4 (1.7)
5.5 (1.6)
0.2 (0.5)
95% CI
2.7 to 8.1
3.0 to 8.6
−0.7 to 1.0
Overall Average (SD)
5.5 (1.4)
5.7 (1.7)
035 (0.9)
95% CI
4.6 to 6.3
4.7 to 6.8
−0.3 to 0.8
Total
6
6
3
The minimum clinical difference (MCID) score was not provided by instrument authors; based on a literature of similar scales of HRQoL, approaching clinical significance is defined here as mean difference >0.8; SD = standard deviation; CI = confidence interval; overall and group analysis of complete data sets only (; per group).
